Delaware lawmakers Wednesday introduced legislation that would force major drug manufacturers to help cover the costs of opioid addiction by imposing a fee on the amount of drugs dispensed in the state.

The measure, Senate Bill 34, would create a two-tier fee on pharmaceutical firms that produce the highest-strength and most widely distributed opioid products available for sale in Delaware, with the proceeds marked for a special fund to pay for treatment and prevention services.